Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT-Reference-Cited by-同舟云学术

Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT

Published:2012-05-17 Issue:20 Volume:119 Page:4813-4815
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Toffalori Cristina¹,Cavattoni Irene²,Deola Sara²,Mastaglio Sara³,Giglio Fabio³,Mazzi Benedetta¹,Assanelli Andrea³,Peccatori Jacopo³,Bordignon Claudio⁴,Bonini Chiara⁵,Cortelazzo Sergio²,Ciceri Fabio³,Fleischhauer Katharina¹,Vago Luca⁶

Affiliation:

1. Unit of Molecular and Functional Immunogenetics, Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute, Milano, Italy

2. Hematology Division, Azienda Sanitaria dell'Alto Adige, Bolzano, Italy

3. Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute, Milano, Italy

4. MolMed S.p.A., Universita' Vita-Salute San Raffaele, San Raffaele Scientific Institute, Milano, Italy

5. Experimental Hematology Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy, Program of Bio-Immunotherapy of Cancer, San Raffaele Scientific Institute, Milano, Italy

6. Hematology and Bone Marrow Transplantation Unit, Unit of Molecular and Functional Immunogenetics, Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute, Milano, Italy

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/119/20/4813/1352623/zh802012004813.pdf

Reference5 articles.

1. Loss of mismatched HLA in leukemia after stem-cell transplantation.;Vago;N Engl J Med,2009

2. Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation.;Villalobos;Blood,2010

3. Genome-wide profiling in AML patients relapsing after allogeneic hematopoietic cell transplantation.;Waterhouse;Biol Blood Marrow Transplant,2011

4. The EBMT activity survey 2009: trends over the past 5 years.;Baldomero;Bone Marrow Transplant,2011

5. Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples.;Cloos;Leukemia,2006

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation—Immune signature correlates with response;British Journal of Haematology;2023-08-04

2. Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells;Blood;2023-04-06

3. Perte d’hétérozygotie HLA dans les rechutes après greffes de cellules souches hématopoïétiques avec donneur non HLA identique : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC);Bulletin du Cancer;2023-04

4. Review: HLA loss and detection in the setting of relapse from HLA-mismatched hematopoietic cell transplant;Human Immunology;2022-10

5. Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes;Cells;2022-07-20